title: Hepatitis B in Pregnancy.
abstract: Chronic hepatitis B virus (HBV) infection is estimated to affect >350 million people worldwide and represents a significant cause of morbidity and mortality related to cirrhosis and hepatocellular carcinoma. Mother-to-child transmission (MTCT) of HBV remains an important source of incident cases of HBV. Current barriers to eradication of incident HBV infections via MTCT include underutilization of immunoprophylaxis with hepatitis B vaccination and hepatitis B immune globulin in certain endemic regions as well as failure of immunoprophylaxis.
authors.affiliation: Liver Transplantation, Cedars-Sinai Medical Center, and David Geffen School of Medicine at UCLA.
authors.forename: Tram T
authors.initials: TT
authors.lastname: Tran
mesh_terms: D000328:Adult; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control / Q000635:transmission / Q000821:virology; D017325:Hepatitis B Vaccines; D006515:Hepatitis B virus; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control / Q000706:statistics & numerical data; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control / Q000821:virology; D055815:Young Adult
chemical_list: D017325:Hepatitis B Vaccines
keywords: hepatitis B; perinatal transmission; pregnancy; vaccination HBIG